(Q44242530)
Statements
1 reference
A phase II study of sorafenib in patients with platinum-pretreated, advanced (Stage IIIb or IV) non-small cell lung cancer with a KRAS mutation (English)
1 reference
1 reference
Danielle A M Heideman
1 reference
Anne-Marie C Dingemans
1 reference
Wouter W Mellema
1 reference
Harry J M Groen
1 reference
Atie van Wijk
1 reference
Sjaak A Burgers
1 reference
Peter W A Kunst
1 reference
Egbert F Smit
1 reference
6 December 2012
1 reference
1 reference
19
1 reference
3
1 reference
743-751
1 reference
Identifiers
1 reference
1 reference